The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the NetherlandsArticle Published on 2023-02-012023-07-10 Journal: HIV medicine [Category] COVID19(2023년), [키워드] COVID-19 men who have sex with men pre-exposure prophylaxis sexual healthcare use sexually transmitted infections [DOI] 10.1111/hiv.13374 PMC 바로가기
Hepatitis A Outbreak in Men Who Have Sex with Men Using Pre-Exposure Prophylaxis and People Living with HIV in Croatia, January to October 2022Review Published on 2022-12-282023-05-31 Journal: Viruses [Category] A형 간염, Fulltext, [키워드] Epidemic hepatitis A HIV men who have sex with men pre-exposure prophylaxis [DOI] 10.3390/v15010087 PMC 바로가기 [Article Type] Review
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a reviewReview Published on 2022-12-012023-07-10 Journal: Expert review of anti-infective therapy [Category] COVID19(2023년), [키워드] cilgavimab COVID-19 Immunocompromised omicron pre-exposure prophylaxis SARS-CoV-2 Tixagevimab Treatment [DOI] 10.1080/14787210.2022.2134118 [Article Type] Review
SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients-A Single-Center ExperienceArticle Published on 2022-10-172023-07-10 Journal: Viruses [Category] COVID19(2023년), [키워드] Immunocompromised patients pre-exposure prophylaxis SARS-CoV-2 PrEP Sotrovimab Tixagevimab/cilgavimab [DOI] 10.3390/v14102278 PMC 바로가기
Current Perspectives on the Determinants of Acceptability of Pre-Exposure Prophylaxis and Nonoccupational Post-Exposure Prophylaxis among People at Risk for HIV: A Scoping ReviewArticle Published on 2022-10-022022-11-15 Journal: International Journal of Environmental Research an [Category] 치료제, [키워드] acceptability Affect collected COVID-19 COVID-19 pandemic current determinant effective exacerbate facilitator Factor Final health system HIV identify inclusion criteria information Intervention knowledge nonoccupational post-exposure prophylaxis pandemic Population pre-exposure prophylaxis Prophylaxis Research retrieved review risk [DOI] 10.3390/ijerph191912605 PMC 바로가기
Low prevalence of hepatitis B virus infection in HIV-uninfected pregnant women in Cape Town, South Africa: implications for oral pre-exposure prophylaxis roll outArticle Published on 2022-09-012023-06-11 Journal: BMC Infectious Diseases [Category] B형 간염, [키워드] hepatitis B HIV pre-exposure prophylaxis pregnant [DOI] 10.1186/s12879-022-07697-5 PMC 바로가기
Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis코로나바이러스 질병 2019(COVID-19)가 인간 면역결핍 바이러스(HIV)에 미치는 영향 미국의 사전 노출 예방 처방-시계열 분석Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] 치료제, [키워드] 95% CI absence affected Algorithm analyzed COVID-19 COVID-19 pandemic database decrease FDA approval greater highlighting HIV Human Impact Intervention maintain National Observed occurred outcome pandemic pre-exposure prophylaxis predicted PrEP prescription Prophylaxis quantified rate ratio reduction the United State The United States United States uptake [DOI] 10.1093/cid/ciac038 PMC 바로가기 [Article Type] Article
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workersResearch article Published on 2022-08-012022-10-05 Journal: Clinical microbiology and infection : the official [Category] SARS, 신약개발, 임상, [키워드] 95% CI 95% CIs Adverse assigned Asymptomatic benefit Combination conducted COVID-19 Daily double-blind eligible event generally mild group HCQ healthcare worker Hydroxychloroquine IgM/IgG individual laboratory-confirmed objective outcome Placebo placebo group placebo-controlled randomized trial pre-exposure prophylaxis Prophylaxis randomized clinical trial randomized trial Randomly Result risk risk ratio Sample size SARS-CoV-2 screened Spain symptomatic TDF/FTC tenofovir tenofovir disoproxil Venezuela was performed [DOI] 10.1016/j.cmi.2022.07.006 [Article Type] Research article
Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic ReviewReview Published on 2022-06-072023-07-09 Journal: JMIR Public Health and Surveillance [Category] COVID19(2023년), [키워드] COVID-19 digital intervention health intervention Health technology HIV HIV prevention pre-exposure prophylaxis public health public health message social media platform systematic review telehealth virtual service virtual service delivery. [DOI] 10.2196/37479 PMC 바로가기 [Article Type] Review
Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision대유행에서 HIV 노출 전 예방에 대한 접근 유지: 전화 기반 노출 전 예방 제공 서비스 평가Article Published on 2022-06-012022-09-11 Journal: International Journal of STD & AIDS [Category] 치료제, [키워드] Administered Care change clinics convenience COVID-19 COVID-19 pandemic delivery Descriptive statistics expressed feasible framework hcp healthcare Healthcare professional HIV HIV pre-exposure prophylaxis increase in maintaining management Patient Patient experience pre-exposure prophylaxis preference PrEP Prophylaxis qualitative data remote Remote access to care required resources response service System Teamwork Tele-medicine the patient turn while [DOI] 10.1177/09564624211068766 PMC 바로가기 [Article Type] Article